CAS 1532593-30-8

ML355 

CAS : 1532593-30-8

Formule : C₂₁H₁₉N₃O₄S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 441.5233

Ref: IN-DA00ABKU

ML355

CAS : 1532593-30-8

ML355

Formule : C₂₁H₁₉N₃O₄S₂

Degré de pureté : ≥95%

Masse moléculaire : 441.52

Ref: 54-BUP15312

ML355

CAS : 1532593-30-8

N-(Benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide

Formule : C₂₁H₁₉N₃O₄S₂

Degré de pureté : 98%

Masse moléculaire : 441.52

Ref: IN-DG630344

ML355

CAS : 1532593-30-8

Formule : C₂₁H₁₉N₃O₄S₂

Masse moléculaire : 441.52

Ref: 4Z-K-031056

ML355

CAS : 1532593-30-8

ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.

Formule : C₂₁H₁₉N₃O₄S₂

Degré de pureté : 97.17% - 98.02%

Couleur et forme : Solid

Masse moléculaire : 441.52

Ref: TM-T4347

ML355

CAS : 1532593-30-8

Ref: BE-RMCK020055

ML355

CAS : 1532593-30-8

ML355 is an antithrombotic agent that inhibits platelet aggregation, which is the first step in the formation of a blood clot. ML355 binds to dinucleotide phosphate (DNP) and blocks polymerase chain reaction (PCR) by preventing DNA synthesis. This drug has potent inhibition of fatty acid synthesis, which is important for cancer and inflammatory diseases. ML355 has also been shown to inhibit collagen-induced platelet aggregation in vitro, suggesting that it may be useful as a treatment for thrombotic disorders.

Formule : C₂₁H₁₉N₃O₄S₂

Degré de pureté : Min. 95%

Masse moléculaire : 441.52 g/mol

Ref: 3D-HLC59330